ConductScience.org, home

Paper25756664

Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging.

Lindenberg L and 11 others. Oncotarget, 2015. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging. Papers, record 25756664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25756664

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging.
PubMed
Journal
Oncotarget
PubMed
Year
2015
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.37
iCite
Revised in PubMed
2021-12-03
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lindenberg LLiza
2Thomas AAnish
3Adler SStephen
4Mena EEsther
5Kurdziel KKaren
6Maltzman JJulia
7Wallin BBruce
8Hoffman KKimberly
9Pastan IIra
10Paik CHChang Hum
11Choyke PPeter
12Hassan RRaffit

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Antibodies, MonoclonalMajor topic
GPI-Linked ProteinsMajor topic
Lung NeoplasmsMajor topic
MesotheliomaMajor topic
Pancreatic NeoplasmsMajor topic
RadiopharmaceuticalsMajor topic
Aged
Female
Humans
Indium Radioisotopes
Male
Mesothelin
Mesothelioma, Malignant
Middle Aged
Tomography, Emission-Computed, Single-Photon

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Intramural NIH HHSUnited StatesPubMedPubMed
ZIABC008753NIHNIH RePORTER
ZIABC010816NIHNIH RePORTER
ZIDBC011540NIHNIH RePORTER

Download CSV of grants

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110942366Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience.Blood2000https://conductscience.org/library/papers/10942366PubMed
211751476Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).Clin Cancer Res2001https://conductscience.org/library/papers/11751476PubMed
314676194Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.J Biol Chem2004https://conductscience.org/library/papers/14676194PubMed
43390350Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma.Am J Physiol Imaging1988https://conductscience.org/library/papers/3390350PubMed
51727378Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.Cancer Res1992https://conductscience.org/library/papers/1727378PubMed
61597725Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.J Nucl Med1992https://conductscience.org/library/papers/1597725PubMed
77568060Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7568060PubMed
88542893The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography.Eur J Nucl Med1995https://conductscience.org/library/papers/8542893PubMed
98552591Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8552591PubMed
109430477Pharmacokinetic modeling and absorbed dose estimation for chimeric anti-CEA antibody in humans.J Nucl Med1997https://conductscience.org/library/papers/9430477PubMed
1115937315OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.J Nucl Med2005https://conductscience.org/library/papers/15937315PubMed
1216082249Localization of mesothelin in epithelial ovarian cancer.Appl Immunohistochem Mol Morphol2005https://conductscience.org/library/papers/16082249PubMed
1316428485Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.Clin Cancer Res2006https://conductscience.org/library/papers/16428485PubMed
1417530026Novel radiolabeled antibody conjugates.Oncogene2007https://conductscience.org/library/papers/17530026PubMed
1517940013Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17940013PubMed
1618088084Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.Cancer Immun2007https://conductscience.org/library/papers/18088084PubMed
1718355690Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.Nucl Med Biol2008https://conductscience.org/library/papers/18355690PubMed
1820357763Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer.Clin Pharmacol Ther2010https://conductscience.org/library/papers/20357763PubMed
1919744744Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.Lung Cancer2010https://conductscience.org/library/papers/19744744PubMed
2021037025Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers.Clin Cancer Res2010https://conductscience.org/library/papers/21037025PubMed

See all 27 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
42638115Immuno-PET imaging of mesothelin in ovarian cancer with 68Ga-XH04: a first-in-human study.Biomark Res2026https://conductscience.org/library/papers/42638115PubMed
41994562Mesothelin biology and the evolving landscape of targeted immunotherapy.Mol Ther Oncol2026https://conductscience.org/library/papers/41994562PubMed
41143950Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural Mesothelioma.Bioconjug Chem2025https://conductscience.org/library/papers/41143950PubMed
41132647High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer.Front Immunol2025https://conductscience.org/library/papers/41132647PubMed
37388728Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies.Front Immunol2023https://conductscience.org/library/papers/37388728PubMed
37195923NAV-001, a high-efficacy antibody-drug conjugate targeting mesothelin with improved delivery of a potent payload by counteracting MUC16/CA125 inhibitory effects.PLoS One2023https://conductscience.org/library/papers/37195923PubMed
35892707Antibody-Based Approaches to Target Pancreatic Tumours.Antibodies (Basel)2022https://conductscience.org/library/papers/35892707PubMed
34522250Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors.Arch Med Sci2021https://conductscience.org/library/papers/34522250PubMed
34439085Hitting the Bull's-Eye: Mesothelin's Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma.Cancers (Basel)2021https://conductscience.org/library/papers/34439085PubMed
34203923Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?Int J Mol Sci2021https://conductscience.org/library/papers/34203923PubMed
33905019
Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model.
Invest New Drugs2021https://conductscience.org/library/papers/33905019PubMed
33418877Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing.Int J Mol Sci2021https://conductscience.org/library/papers/33418877PubMed
32605175Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors.Biomolecules2020https://conductscience.org/library/papers/32605175PubMed
32517181From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.Int J Mol Sci2020https://conductscience.org/library/papers/32517181PubMed
32314552Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies.Wiley Interdiscip Rev Nanomed Nanobiotechnol2020https://conductscience.org/library/papers/32314552PubMed
32202104ImmunoPET: Concept, Design, and Applications.Chem Rev2020https://conductscience.org/library/papers/32202104PubMed
31463062Mesothelin as a biomarker for targeted therapy.Biomark Res2019https://conductscience.org/library/papers/31463062PubMed
30344925Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models.Oncotarget2018https://conductscience.org/library/papers/30344925PubMed
30333914The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model.Oncotarget2018https://conductscience.org/library/papers/30333914PubMed
30225616Translational molecular imaging in exocrine pancreatic cancer.Eur J Nucl Med Mol Imaging2018https://conductscience.org/library/papers/30225616PubMed

See all 28 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FOLR12348PubTator's text mininghttps://conductscience.org/library/genes/2348NCBI Gene
MSLN10232PubTator's text mininghttps://conductscience.org/library/genes/10232NCBI Gene
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25756664

GET https://conductscience.org/api/papers/v1/25756664/references?page=2